首页 > 最新文献

Frontiers in bioscience (Scholar edition)最新文献

英文 中文
MicroRNA Regulation of Bone Marrow Mesenchymal Stem Cells in the Development of Osteoporosis in Obesity. 骨髓间充质干细胞在肥胖骨质疏松发生中的MicroRNA调控。
Pub Date : 2022-06-23 DOI: 10.31083/j.fbs1403017
Maria Vulf, Igor Khlusov, Kristina Yurova, Natalia Todosenko, Alexandra Komar, Ivan Kozlov, Vladimir Malashchenko, Daria Shunkina, Olga Khaziakhmatova, Larisa Litvinova

Obesity and osteoporosis are global health problems characterized by high rates of prevalence and mortality due to complications. As people with visceral obesity age, the adipogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) increases, and adipocytes become the predominant stromal cells in the bone marrow microenvironment, which hinders the physiological regeneration and mineralization of bone tissue. Primary and secondary osteoporosis remain severe progressive diseases. Both osteoporosis and obesity are associated with microRNAs (miRNAs) that induce adipogenesis and osteoresorption. This review presents analyses of the roles and clinical potential of miRNAs in the epigenetic control of BMSC differentiation and the formation and function of osteoclasts in osteoporosis with and without obesity. Understanding the fine-tuned regulation of the expression of genes critical for the balance of osteogenesis/osteolysis processes may provide hope for the development of effective and safe osteoporosis therapies in the future.

肥胖和骨质疏松症是全球性的健康问题,其特点是发病率和并发症死亡率都很高。随着肥胖者年龄的增长,骨髓间充质干细胞(BMSCs)的成脂分化增加,脂肪细胞成为骨髓微环境中占优势的基质细胞,阻碍了骨组织的生理性再生和矿化。原发性和继发性骨质疏松症仍然是严重的进行性疾病。骨质疏松和肥胖都与诱导脂肪生成和骨吸收的microRNAs (miRNAs)有关。本文综述了mirna在伴有和不伴有肥胖的骨质疏松症中BMSC分化的表观遗传控制以及破骨细胞的形成和功能中的作用和临床潜力。了解对成骨/溶骨过程平衡至关重要的基因表达的微调调控可能为未来开发有效和安全的骨质疏松症治疗提供希望。
{"title":"MicroRNA Regulation of Bone Marrow Mesenchymal Stem Cells in the Development of Osteoporosis in Obesity.","authors":"Maria Vulf,&nbsp;Igor Khlusov,&nbsp;Kristina Yurova,&nbsp;Natalia Todosenko,&nbsp;Alexandra Komar,&nbsp;Ivan Kozlov,&nbsp;Vladimir Malashchenko,&nbsp;Daria Shunkina,&nbsp;Olga Khaziakhmatova,&nbsp;Larisa Litvinova","doi":"10.31083/j.fbs1403017","DOIUrl":"https://doi.org/10.31083/j.fbs1403017","url":null,"abstract":"<p><p>Obesity and osteoporosis are global health problems characterized by high rates of prevalence and mortality due to complications. As people with visceral obesity age, the adipogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) increases, and adipocytes become the predominant stromal cells in the bone marrow microenvironment, which hinders the physiological regeneration and mineralization of bone tissue. Primary and secondary osteoporosis remain severe progressive diseases. Both osteoporosis and obesity are associated with microRNAs (miRNAs) that induce adipogenesis and osteoresorption. This review presents analyses of the roles and clinical potential of miRNAs in the epigenetic control of BMSC differentiation and the formation and function of osteoclasts in osteoporosis with and without obesity. Understanding the fine-tuned regulation of the expression of genes critical for the balance of osteogenesis/osteolysis processes may provide hope for the development of effective and safe osteoporosis therapies in the future.</p>","PeriodicalId":73070,"journal":{"name":"Frontiers in bioscience (Scholar edition)","volume":"14 3","pages":"17"},"PeriodicalIF":0.0,"publicationDate":"2022-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33470211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
An Updated Review on The Properties of Melissa officinalis L.: Not Exclusively Anti-anxiety. 梅莉莎抗焦虑作用的最新研究进展。
Pub Date : 2022-06-07 DOI: 10.31083/j.fbs1402016
Wissam Zam, Cristina Quispe, Javad Sharifi-Rad, María Dolores López, Mauricio Schoebitz, Miquel Martorell, Farukh Sharopov, Patrick Valere Tsouh Fokou, Abhay Prakash Mishra, Deepak Chandran, Manoj Kumar, Jen-Tsung Chen, Raffaele Pezzani

Melissa officinalis L. is a plant of the Lamiaceae family known in numerous countries for its medicinal activities. This plant has been used since ancient times to treat different disorders, including gastrointestinal, cardiovascular, neurological, psychological conditions. M. officinalis contains several phytochemicals such as phenolic acids, flavonoids, terpenoids, and many others at the basis of its pharmacological activities. Indeed, the plant can have antioxidant, anti-inflammatory, antispasmodic, antimicrobial, neuroprotective, nephroprotective, antinociceptive effects. Given its consolidated use, M. officinalis has also been experimented with clinical settings, demonstrating interesting properties against different human diseases, such as anxiety, sleeping difficulties, palpitation, hypertension, depression, dementia, infantile colic, bruxism, metabolic problems, Alzheimer's disease, and sexual disorders. As for any natural compound, drug, or plant extract, also M. officinalis can have adverse effects, even though the reported events are very rare and the plant can be considered substantially safe. This review has been prepared with a specific research strategy, interrogating different databases with the keyword M. officinalis. Moreover, this work analyzes the properties of this plant updating currently available literature, with a special emphasis on human studies.

Melissa officinalis L.是Lamiaceae家族的一种植物,在许多国家因其药用活性而闻名。自古以来,这种植物就被用来治疗各种疾病,包括胃肠道、心血管、神经系统和心理疾病。在其药理活性的基础上,officinalis含有几种植物化学物质,如酚酸、黄酮类化合物、萜类化合物和许多其他物质。事实上,这种植物具有抗氧化、抗炎、抗痉挛、抗菌、神经保护、肾保护、抗伤等作用。鉴于其综合用途,officinalis也在临床环境中进行了实验,显示出对不同人类疾病的有趣特性,如焦虑、睡眠困难、心悸、高血压、抑郁、痴呆、婴儿绞痛、磨牙症、代谢问题、阿尔茨海默病和性功能障碍。与任何天然化合物、药物或植物提取物一样,马毒草也可能有副作用,尽管报道的事件非常罕见,而且这种植物可以被认为是非常安全的。这篇综述已经准备了一个特定的研究策略,询问不同的数据库与关键词M. officinalis。此外,本文分析了该植物的特性,更新了现有文献,特别强调了人类的研究。
{"title":"An Updated Review on The Properties of <i>Melissa officinalis</i> L.: Not Exclusively Anti-anxiety.","authors":"Wissam Zam,&nbsp;Cristina Quispe,&nbsp;Javad Sharifi-Rad,&nbsp;María Dolores López,&nbsp;Mauricio Schoebitz,&nbsp;Miquel Martorell,&nbsp;Farukh Sharopov,&nbsp;Patrick Valere Tsouh Fokou,&nbsp;Abhay Prakash Mishra,&nbsp;Deepak Chandran,&nbsp;Manoj Kumar,&nbsp;Jen-Tsung Chen,&nbsp;Raffaele Pezzani","doi":"10.31083/j.fbs1402016","DOIUrl":"https://doi.org/10.31083/j.fbs1402016","url":null,"abstract":"<p><p><i>Melissa officinalis</i> L. is a plant of the Lamiaceae family known in numerous countries for its medicinal activities. This plant has been used since ancient times to treat different disorders, including gastrointestinal, cardiovascular, neurological, psychological conditions. <i>M. officinalis</i> contains several phytochemicals such as phenolic acids, flavonoids, terpenoids, and many others at the basis of its pharmacological activities. Indeed, the plant can have antioxidant, anti-inflammatory, antispasmodic, antimicrobial, neuroprotective, nephroprotective, antinociceptive effects. Given its consolidated use, <i>M. officinalis</i> has also been experimented with clinical settings, demonstrating interesting properties against different human diseases, such as anxiety, sleeping difficulties, palpitation, hypertension, depression, dementia, infantile colic, bruxism, metabolic problems, Alzheimer's disease, and sexual disorders. As for any natural compound, drug, or plant extract, also <i>M. officinalis</i> can have adverse effects, even though the reported events are very rare and the plant can be considered substantially safe. This review has been prepared with a specific research strategy, interrogating different databases with the keyword <i>M. officinalis</i>. Moreover, this work analyzes the properties of this plant updating currently available literature, with a special emphasis on human studies.</p>","PeriodicalId":73070,"journal":{"name":"Frontiers in bioscience (Scholar edition)","volume":"14 2","pages":"16"},"PeriodicalIF":0.0,"publicationDate":"2022-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40176964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Dynamic Profiling of Exosomal microRNAs in Blood Plasma of Patients with Castration-Resistant Prostate Cancer. 去势抵抗性前列腺癌患者血浆外泌体microrna的动态分析
Pub Date : 2022-05-23 DOI: 10.31083/j.fbs1402015
Elena A Pudova, Anastasiya A Kobelyatskaya, Irina V Katunina, Anastasiya V Snezhkina, Maria S Fedorova, Zulfiya G Guvatova, Kirill M Nyushko, Boris Y Alekseev, Vladislav S Pavlov, Maria V Savvateeva, Alexander A Kudryavtsev, George S Krasnov, Anna V Kudryavtseva

Prostate cancer is one of the most common and socially significant cancers among men. The aim of this study was to identify significant changes in the expression of exosomal miRNAs associated with an increase in the level of prostate specific antigen in castration-resistant prostate cancer during therapy and to evaluate them as potential prognostic markers for this category of disease. High-throughput miRNA sequencing was performed on 49 blood plasma samples taken from 11 Russian patients with castration-resistant cancer during therapy. Bioinformatic analysis of the obtained miRNA-seq data was carried out. Additionally, miRNA-seq data from the PRJNA562276 project were analyzed to identify exosomal miRNAs associated with castration-resistant prostate cancer. We found 34 differentially expressed miRNAs associated with the progression of castration-resistant prostate cancer during therapy in Russian patients. It was also shown that hsa-miRNA-148a-3p expression can serve as a potential prognostic marker. We found the exosomal miRNA expression signature associated with castration-resistant prostate cancer progression, in particular on the Russian patient cohort. Many of these miRNAs are well-known players in either oncogenic transformation or tumor suppression. Further experimental studies with extended sampling are required to validate these results.

前列腺癌是男性中最常见和最具社会意义的癌症之一。本研究的目的是确定在去势抵抗性前列腺癌治疗期间与前列腺特异性抗原水平升高相关的外泌体mirna表达的显著变化,并评估其作为这类疾病的潜在预后标志物。对11名俄罗斯去势抵抗性癌症患者在治疗期间采集的49份血浆样本进行了高通量miRNA测序。对获得的miRNA-seq数据进行生物信息学分析。此外,我们分析了PRJNA562276项目的miRNA-seq数据,以鉴定与去势抵抗性前列腺癌相关的外泌体mirna。我们发现34个差异表达的mirna与俄罗斯患者治疗期间去势抵抗性前列腺癌的进展相关。研究还表明,hsa-miRNA-148a-3p的表达可以作为潜在的预后指标。我们发现外泌体miRNA表达特征与去势抵抗性前列腺癌进展相关,特别是在俄罗斯患者队列中。这些mirna中的许多都是众所周知的致癌转化或肿瘤抑制的参与者。需要进一步扩大取样的实验研究来验证这些结果。
{"title":"Dynamic Profiling of Exosomal microRNAs in Blood Plasma of Patients with Castration-Resistant Prostate Cancer.","authors":"Elena A Pudova,&nbsp;Anastasiya A Kobelyatskaya,&nbsp;Irina V Katunina,&nbsp;Anastasiya V Snezhkina,&nbsp;Maria S Fedorova,&nbsp;Zulfiya G Guvatova,&nbsp;Kirill M Nyushko,&nbsp;Boris Y Alekseev,&nbsp;Vladislav S Pavlov,&nbsp;Maria V Savvateeva,&nbsp;Alexander A Kudryavtsev,&nbsp;George S Krasnov,&nbsp;Anna V Kudryavtseva","doi":"10.31083/j.fbs1402015","DOIUrl":"https://doi.org/10.31083/j.fbs1402015","url":null,"abstract":"<p><p>Prostate cancer is one of the most common and socially significant cancers among men. The aim of this study was to identify significant changes in the expression of exosomal miRNAs associated with an increase in the level of prostate specific antigen in castration-resistant prostate cancer during therapy and to evaluate them as potential prognostic markers for this category of disease. High-throughput miRNA sequencing was performed on 49 blood plasma samples taken from 11 Russian patients with castration-resistant cancer during therapy. Bioinformatic analysis of the obtained miRNA-seq data was carried out. Additionally, miRNA-seq data from the PRJNA562276 project were analyzed to identify exosomal miRNAs associated with castration-resistant prostate cancer. We found 34 differentially expressed miRNAs associated with the progression of castration-resistant prostate cancer during therapy in Russian patients. It was also shown that hsa-miRNA-148a-3p expression can serve as a potential prognostic marker. We found the exosomal miRNA expression signature associated with castration-resistant prostate cancer progression, in particular on the Russian patient cohort. Many of these miRNAs are well-known players in either oncogenic transformation or tumor suppression. Further experimental studies with extended sampling are required to validate these results.</p>","PeriodicalId":73070,"journal":{"name":"Frontiers in bioscience (Scholar edition)","volume":"14 2","pages":"15"},"PeriodicalIF":0.0,"publicationDate":"2022-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40176035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Anti-Oxidative Therapy in Diabetic Nephropathy. 糖尿病肾病的抗氧化治疗。
Pub Date : 2022-05-09 DOI: 10.31083/j.fbs1402014
Luis F Hernandez, Natsuki Eguchi, David Whaley, Michael Alexander, Ekamol Tantisattamo, Hirohito Ichii

Chronic kidney disease is generally progressive and currently has no reliable treatment to reverse a decline in kidney function or to slow the progression of the disease. Diabetic nephropathy is one of the leading causes of end-stage kidney failure. Kidney damage in diabetic nephropathy is largely attributed to the increased oxidative stress, affecting its metabolic activity, metabolic pathways, and hemodynamic pathways. In diabetic patients, hyperglycemia causes an increase in the production of reactive oxygen species that further increase oxidative stress. These reactive oxygen species are created through a variety of pathways, providing the opportunity for treatment using anti-oxidative defense mechanisms to prevent vascular injury. This review will give an overview of oxidative stress, along with the current treatments and limitations of diabetic nephropathy. We will also discuss the potential of antioxidative therapies, with an emphasis on the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway.

慢性肾脏疾病通常是进行性的,目前没有可靠的治疗方法来逆转肾功能下降或减缓疾病的进展。糖尿病肾病是终末期肾衰竭的主要原因之一。糖尿病肾病肾损害主要归因于氧化应激增加,影响其代谢活性、代谢途径和血流动力学途径。在糖尿病患者中,高血糖会导致活性氧的产生增加,从而进一步增加氧化应激。这些活性氧通过多种途径产生,提供了使用抗氧化防御机制来预防血管损伤的治疗机会。这篇综述将给出氧化应激的概述,以及目前的治疗方法和糖尿病肾病的局限性。我们还将讨论抗氧化治疗的潜力,重点是核因子红细胞2相关因子2 (Nrf2)途径。
{"title":"Anti-Oxidative Therapy in Diabetic Nephropathy.","authors":"Luis F Hernandez,&nbsp;Natsuki Eguchi,&nbsp;David Whaley,&nbsp;Michael Alexander,&nbsp;Ekamol Tantisattamo,&nbsp;Hirohito Ichii","doi":"10.31083/j.fbs1402014","DOIUrl":"https://doi.org/10.31083/j.fbs1402014","url":null,"abstract":"<p><p>Chronic kidney disease is generally progressive and currently has no reliable treatment to reverse a decline in kidney function or to slow the progression of the disease. Diabetic nephropathy is one of the leading causes of end-stage kidney failure. Kidney damage in diabetic nephropathy is largely attributed to the increased oxidative stress, affecting its metabolic activity, metabolic pathways, and hemodynamic pathways. In diabetic patients, hyperglycemia causes an increase in the production of reactive oxygen species that further increase oxidative stress. These reactive oxygen species are created through a variety of pathways, providing the opportunity for treatment using anti-oxidative defense mechanisms to prevent vascular injury. This review will give an overview of oxidative stress, along with the current treatments and limitations of diabetic nephropathy. We will also discuss the potential of antioxidative therapies, with an emphasis on the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway.</p>","PeriodicalId":73070,"journal":{"name":"Frontiers in bioscience (Scholar edition)","volume":"14 2","pages":"14"},"PeriodicalIF":0.0,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40178493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
The Effects of Novel Formulations of Edaravone and Curcumin in the Mouse Intrastriatal Lipopolysaccharide Model of Parkinson's Disease. 新剂型依达拉奉和姜黄素对帕金森病小鼠胃内脂多糖模型的影响。
Pub Date : 2022-05-07 DOI: 10.31083/j.fbs1402013
Isaac Deng, Sanjay Garg, Xin-Fu Zhou, Larisa Bobrovskaya
The major hallmark of Parkinson's disease (PD) is the degeneration of dopaminergic neurons in the substantia nigra (SN), which is responsible for the core motor symptoms of PD. Currently, there is no cure for PD, and its prevalence is increasing, prompting the search for novel neuroprotective treatments. Neuroinflammation is a core pathological process in PD, evident by increased inflammatory biomarkers in the SN and cerebrospinal fluid. Interestingly, epidemiological studies have reported a reduced risk of PD in users of non-steroidal anti-inflammatory drugs compared to non-users, suggesting the neuroprotective potential of anti-inflammatory drugs. Therefore, this study aimed to: (1) test the efficacy of novel oral formulations of edaravone (EDR) and curcumin (CUR) (which possess anti-inflammatory and anti-oxidative properties) to alleviate motor and non-motor symptoms, and associated pathology in the intrastriatal lipopolysaccharide (LPS) model of PD; (2) investigate the expression of proteins linked to familial PD and markers of autophagy in the intrastriatal LPS model treated with EDR and CUR. Fifty-two C57BL/6 mice were divided into 4 groups, namely; (1) control + vehicle; (2) LPS + vehicle; (3) LPS + EDR (made in vehicle) and (4) LPS + CUR (made in vehicle). 10 μg of LPS was administered stereotaxically into the right striatum, and EDR and CUR treatments were initiated 2-weeks after the LPS injections. Behavioural tests were carried out at 4- and 8-weeks after LPS injection followed by tissue collection at 8-weeks. Intrastriatal administration of LPS induced motor deficits and anxiety-like behaviours at 4- and 8-weeks, which were accompanied by astroglial activation, increased protein expression of α-synuclein, heat shock cognate protein of 70 kDa (HSC-70) and Rab-10, and reduced levels of tyrosine hydroxylase (TH) protein in the striatum. Additionally, LPS induced astroglial activation in the olfactory bulb, along with changes in the protein expression of HSC-70. The changes associated with EDR and CUR in the striatum and olfactory bulb were not statistically significant compared to the LPS group. Intrastriatal administration of LPS induced pathological changes of PD such as motor deficits, reduced expression of TH protein and increased α-synuclein protein, as well as some alterations in proteins linked to familial PD and autophagy in the olfactory bulb and striatum, without pronounced therapeutic effects of EDR and CUR. Our results may suggest that EDR and CUR lack therapeutic effects when administered after the disease process was already initiated. Thus, our treatment regimen or the physicochemical properties of EDR and CUR could be further refined to elevate the therapeutic effects of these formulations.
帕金森病(PD)的主要标志是黑质(SN)多巴胺能神经元的退化,这是PD的核心运动症状的原因。目前,PD无法治愈,其患病率正在上升,促使人们寻找新的神经保护治疗方法。神经炎症是帕金森病的核心病理过程,SN和脑脊液中的炎症生物标志物增加。有趣的是,流行病学研究表明,与非甾体抗炎药使用者相比,非甾体抗炎药的使用者患PD的风险降低,这表明抗炎药具有神经保护作用。因此,本研究旨在:(1)研究新型口服依达拉单(EDR)和姜黄素(CUR)(具有抗炎和抗氧化特性)对帕金森病(PD)的运动和非运动症状及其相关病理的缓解作用;(2)研究EDR和CUR处理的胃内LPS模型中家族性PD相关蛋白和自噬标志物的表达情况。(1)控制+车辆;(2) LPS +载体;(3) LPS + EDR(车制)和(4)LPS + CUR(车制)。LPS立体定向注入大鼠右侧纹状体10 μg,注射后2周开始EDR和CUR治疗。在LPS注射后4周和8周进行行为测试,并在8周收集组织。在4周和8周时,纹状体内给药LPS诱导运动缺陷和焦虑样行为,并伴有星形胶质细胞活化,α-突触核蛋白、70 kDa热休克同源蛋白(HSC-70)和Rab-10的蛋白表达增加,纹状体中酪氨酸羟化酶(TH)蛋白水平降低。此外,LPS诱导嗅球星形胶质细胞激活,同时改变HSC-70的蛋白表达。纹状体和嗅球中EDR和CUR相关的变化与LPS组相比无统计学意义。纹状体内给药LPS可引起PD的病理改变,如运动障碍、TH蛋白表达降低、α-突触核蛋白升高,以及家族性PD相关蛋白和嗅球和纹状体自噬的一些改变,而EDR和CUR没有明显的治疗作用。我们的研究结果可能表明,在疾病进程已经开始后给药EDR和CUR缺乏治疗作用。因此,我们的治疗方案或EDR和CUR的物理化学性质可以进一步完善,以提高这些配方的治疗效果。
{"title":"The Effects of Novel Formulations of Edaravone and Curcumin in the Mouse Intrastriatal Lipopolysaccharide Model of Parkinson's Disease.","authors":"Isaac Deng,&nbsp;Sanjay Garg,&nbsp;Xin-Fu Zhou,&nbsp;Larisa Bobrovskaya","doi":"10.31083/j.fbs1402013","DOIUrl":"https://doi.org/10.31083/j.fbs1402013","url":null,"abstract":"The major hallmark of Parkinson's disease (PD) is the degeneration of dopaminergic neurons in the substantia nigra (SN), which is responsible for the core motor symptoms of PD. Currently, there is no cure for PD, and its prevalence is increasing, prompting the search for novel neuroprotective treatments. Neuroinflammation is a core pathological process in PD, evident by increased inflammatory biomarkers in the SN and cerebrospinal fluid. Interestingly, epidemiological studies have reported a reduced risk of PD in users of non-steroidal anti-inflammatory drugs compared to non-users, suggesting the neuroprotective potential of anti-inflammatory drugs. Therefore, this study aimed to: (1) test the efficacy of novel oral formulations of edaravone (EDR) and curcumin (CUR) (which possess anti-inflammatory and anti-oxidative properties) to alleviate motor and non-motor symptoms, and associated pathology in the intrastriatal lipopolysaccharide (LPS) model of PD; (2) investigate the expression of proteins linked to familial PD and markers of autophagy in the intrastriatal LPS model treated with EDR and CUR. Fifty-two C57BL/6 mice were divided into 4 groups, namely; (1) control + vehicle; (2) LPS + vehicle; (3) LPS + EDR (made in vehicle) and (4) LPS + CUR (made in vehicle). 10 μg of LPS was administered stereotaxically into the right striatum, and EDR and CUR treatments were initiated 2-weeks after the LPS injections. Behavioural tests were carried out at 4- and 8-weeks after LPS injection followed by tissue collection at 8-weeks. Intrastriatal administration of LPS induced motor deficits and anxiety-like behaviours at 4- and 8-weeks, which were accompanied by astroglial activation, increased protein expression of α-synuclein, heat shock cognate protein of 70 kDa (HSC-70) and Rab-10, and reduced levels of tyrosine hydroxylase (TH) protein in the striatum. Additionally, LPS induced astroglial activation in the olfactory bulb, along with changes in the protein expression of HSC-70. The changes associated with EDR and CUR in the striatum and olfactory bulb were not statistically significant compared to the LPS group. Intrastriatal administration of LPS induced pathological changes of PD such as motor deficits, reduced expression of TH protein and increased α-synuclein protein, as well as some alterations in proteins linked to familial PD and autophagy in the olfactory bulb and striatum, without pronounced therapeutic effects of EDR and CUR. Our results may suggest that EDR and CUR lack therapeutic effects when administered after the disease process was already initiated. Thus, our treatment regimen or the physicochemical properties of EDR and CUR could be further refined to elevate the therapeutic effects of these formulations.","PeriodicalId":73070,"journal":{"name":"Frontiers in bioscience (Scholar edition)","volume":"14 2","pages":"13"},"PeriodicalIF":0.0,"publicationDate":"2022-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40178492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A Possible Synergistic Herbal Solution for COVID-19. 新型冠状病毒肺炎可能的协同草药解决方案
Pub Date : 2022-05-06 DOI: 10.31083/j.fbs1402012
Ephraim Shmaya Lansky

The COVID-19 pandemic has provided an opportunity for repurposing of drugs, including complex, natural drugs, to meet the global need for safe and effective antiviral medicines which do not promote multidrug resistance nor inflate medical costs. The author herein describes his own repurposing of herbal tinctures, previously prepared for oncology, into a possibly synergistic, anti-COVID 41 "herb" formula of extracts derived from 36 different plants and medicinal mushrooms. A method of multi-sample in vitro testing in green monkey kidney vero cells is proposed for testing the Hypothesis that even in such a large combination, antiviral potency may be preserved, along with therapeutic synergy, smoothness, and complexity. The possibility that the formula's potency may improve with age is considered, along with a suitable method for testing it. Collaborative research inquiries are welcome.

COVID-19大流行为重新利用药物(包括复杂的天然药物)提供了机会,以满足全球对安全有效的抗病毒药物的需求,这些药物不会促进多药耐药性,也不会增加医疗费用。作者在此描述了他自己对以前为肿瘤学准备的草药酊剂的重新利用,将其转化为一种可能具有协同作用的抗covid - 41“草药”配方,该配方来自36种不同的植物和药用蘑菇的提取物。提出了一种在绿猴肾vero细胞中进行多样本体外测试的方法,以验证即使在如此大的组合中,抗病毒效力也可以保留,同时具有治疗协同作用,平滑性和复杂性。该配方的效力可能会随着年龄的增长而提高,并考虑了一种合适的测试方法。欢迎合作研究咨询。
{"title":"A Possible Synergistic Herbal Solution for COVID-19.","authors":"Ephraim Shmaya Lansky","doi":"10.31083/j.fbs1402012","DOIUrl":"https://doi.org/10.31083/j.fbs1402012","url":null,"abstract":"<p><p>The COVID-19 pandemic has provided an opportunity for repurposing of drugs, including complex, natural drugs, to meet the global need for safe and effective antiviral medicines which do not promote multidrug resistance nor inflate medical costs. The author herein describes his own repurposing of herbal tinctures, previously prepared for oncology, into a possibly synergistic, anti-COVID 41 \"herb\" formula of extracts derived from 36 different plants and medicinal mushrooms. A method of multi-sample <i>in vitro</i> testing in green monkey kidney vero cells is proposed for testing the Hypothesis that even in such a large combination, antiviral potency may be preserved, along with therapeutic synergy, smoothness, and complexity. The possibility that the formula's potency may improve with age is considered, along with a suitable method for testing it. Collaborative research inquiries are welcome.</p>","PeriodicalId":73070,"journal":{"name":"Frontiers in bioscience (Scholar edition)","volume":"14 2","pages":"12"},"PeriodicalIF":0.0,"publicationDate":"2022-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40178491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Assessment of Antimicrobial Activity of Ethanolic and Aqueous Extracts of Aesculus hippocastanum L. (Horse Chestnut) Bark against Bacteria Isolated from Urine of Patients Diagnosed Positive to Urinary Tract Infections. 七叶树树皮醇提液和水提液对尿路感染阳性患者尿液细菌的抑菌活性评价
Pub Date : 2022-04-02 DOI: 10.31083/j.fbs1402011
Khar'kov Y Konstantinovitch, Mbarga M J Arsene, Martynenkova V Aliya, Podoprigora I Viktorovna, Volina G Elena, Madina M Azova, Ait A Amira

The search for new antimicrobials is essential to address the worldwide issue of antibiotic resistance. The present work aimed at assessing the antimicrobial activity of Aesculus hippocastanum L. (horse chestnut) bark against bacteria involved in urinary tract infections (UTIs). Bioactive compounds were extracted from A. hippocastanum bark using water and ethanol as solvents. The extracts were tested against 10 clinical uropathogenic strains including five Gram-positive and five Gram-negative bacteria. Staphylococcus aureus ATCC 6538 and Escherichia coli ATCC 25922 were used as reference bacteria. The susceptibility to antibiotics was assessed using the Kirby Bauer disc diffusion method and the antibacterial activity of the extracts was evaluated using the well diffusion method. The Minimum inhibitory concentration (MIC) and the minimum bactericidal concentrations (MBC) were asseded by the microdilution method. A. hippocastanum bark possessed a dry matter content of 65.73%. The aqueous extract (AE) and ethanolic extract (EE) showed a volume yield of 77.77% and 74.07% (v/v), and a mass yields of 13.4% and 24.3% (w/w) respectively. All the bacteria were susceptible to amoxiclav, imipenem and ceftriaxone but the clinical strains were resistant to at least one antibiotic. Kocuria rizophilia 1542 and Corynebacterium spp 1638 were the most resistant bacteria both with multidrug resistance index of 0.45. Except AE on Proteus Mirabilis 1543 and Enterococcus faecalis 5960 (0 mm), both AE and EE were active against all the microorganisms tested with inhibition diameters (mm) which ranged from 5.5-10.0 for AE and 8.0-14.5 for EE. The MICs of EEs varied from 1-4 mg/mL while those of AEs varied from 4-16 mg/mL. The ethanolic extracts (EE) were overall more active than the aqueous ones. The A. hippocastanum bark extracts had overall weak antibacterial activity (MIC ≥0.625 mg/mL) and bacteriostatic potential (MBC/MIC ≥16) on both Gram-positive and Gram-negative bacteria.

寻找新的抗微生物药物对于解决全球抗生素耐药性问题至关重要。本研究旨在研究七叶树树皮对尿路感染细菌的抑菌活性。以水和乙醇为溶剂,从马尾松树皮中提取生物活性物质。对10种临床尿路病原菌进行了抑菌试验,其中革兰氏阳性菌5株,革兰氏阴性菌5株。以金黄色葡萄球菌ATCC 6538和大肠杆菌ATCC 25922为对照菌。采用Kirby Bauer盘片扩散法测定其对抗生素的敏感性,采用孔扩散法测定其抑菌活性。用微量稀释法测定最小抑菌浓度(MIC)和最小杀菌浓度(MBC)。马皮干物质含量为65.73%。水提物(AE)和乙醇提物(EE)的体积得率分别为77.77%和74.07% (v/v),质量得率分别为13.4%和24.3% (w/w)。所有细菌均对阿莫昔拉夫、亚胺培南和头孢曲松敏感,但临床菌株对至少一种抗生素耐药。最耐药菌为嗜利谷杆菌1542和棒状杆菌1638,多重耐药指数均为0.45。除AE对奇异变形杆菌1543和粪肠球菌5960 (0 mm)有抑制作用外,AE和EE对所有微生物均有抑制作用,抑菌直径为5.5 ~ 10.0 mm, EE抑菌直径为8.0 ~ 14.5 mm。EEs的mic值为1 ~ 4 mg/mL, ae的mic值为4 ~ 16 mg/mL。乙醇提取物(EE)总体上比水提取物更有活性。对革兰氏阳性菌和革兰氏阴性菌均有较弱的抑菌活性(MIC≥0.625 mg/mL)和抑菌电位(MBC/MIC≥16)。
{"title":"Assessment of Antimicrobial Activity of Ethanolic and Aqueous Extracts of <i>Aesculus hippocastanum</i> L. (Horse Chestnut) Bark against Bacteria Isolated from Urine of Patients Diagnosed Positive to Urinary Tract Infections.","authors":"Khar'kov Y Konstantinovitch,&nbsp;Mbarga M J Arsene,&nbsp;Martynenkova V Aliya,&nbsp;Podoprigora I Viktorovna,&nbsp;Volina G Elena,&nbsp;Madina M Azova,&nbsp;Ait A Amira","doi":"10.31083/j.fbs1402011","DOIUrl":"https://doi.org/10.31083/j.fbs1402011","url":null,"abstract":"<p><p>The search for new antimicrobials is essential to address the worldwide issue of antibiotic resistance. The present work aimed at assessing the antimicrobial activity of <i>Aesculus hippocastanum</i> L. (horse chestnut) bark against bacteria involved in urinary tract infections (UTIs). Bioactive compounds were extracted from <i>A. hippocastanum</i> bark using water and ethanol as solvents. The extracts were tested against 10 clinical uropathogenic strains including five Gram-positive and five Gram-negative bacteria. <i>Staphylococcus aureus</i> ATCC 6538 and <i>Escherichia coli</i> ATCC 25922 were used as reference bacteria. The susceptibility to antibiotics was assessed using the Kirby Bauer disc diffusion method and the antibacterial activity of the extracts was evaluated using the well diffusion method. The Minimum inhibitory concentration (MIC) and the minimum bactericidal concentrations (MBC) were asseded by the microdilution method. <i>A. hippocastanum</i> bark possessed a dry matter content of 65.73%. The aqueous extract (AE) and ethanolic extract (EE) showed a volume yield of 77.77% and 74.07% (v/v), and a mass yields of 13.4% and 24.3% (w/w) respectively. All the bacteria were susceptible to amoxiclav, imipenem and ceftriaxone but the clinical strains were resistant to at least one antibiotic. <i>Kocuria rizophilia</i> 1542 and <i>Corynebacterium</i> spp 1638 were the most resistant bacteria both with multidrug resistance index of 0.45. Except AE on <i>Proteus Mirabilis</i> 1543 and <i>Enterococcus faecalis</i> 5960 (0 mm), both AE and EE were active against all the microorganisms tested with inhibition diameters (mm) which ranged from 5.5-10.0 for AE and 8.0-14.5 for EE. The MICs of EEs varied from 1-4 mg/mL while those of AEs varied from 4-16 mg/mL. The ethanolic extracts (EE) were overall more active than the aqueous ones. The <i>A. hippocastanum</i> bark extracts had overall weak antibacterial activity (MIC ≥0.625 mg/mL) and bacteriostatic potential (MBC/MIC ≥16) on both Gram-positive and Gram-negative bacteria.</p>","PeriodicalId":73070,"journal":{"name":"Frontiers in bioscience (Scholar edition)","volume":"14 2","pages":"11"},"PeriodicalIF":0.0,"publicationDate":"2022-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40178490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Antispasmodic Effect of Warionia saharae Essential Oil in Experimental Models and its Mechanism of Action. 撒哈拉Warionia挥发油的抗痉挛作用及其作用机制。
Pub Date : 2022-03-31 DOI: 10.31083/j.fbs1402010
Ouafa Amrani, Mohamed Marghich, Mohamed Addi, Christophe Hano, Jen-Tsung Chen, Hanane Makrane, Chakib Alem, Ahmed Karim, Mohammed Aziz

With several medicinal and aromatic species, the Asteraceae family is one of the largest angiosperm families. The genus Warionia is represented in this family by only one species, Warionia saharae. In Moroccan traditional medicine, this species is widely used to treat gastrointestinal problems. Essential oil of this plant (EoWs) was studied for possible myorelaxant and antispasmodic activities to rationalize some of the traditional uses. In this investigation, hydrodistillation was used to obtain the essential oil from the aerial part of the dry plant extract (EoWs), which was then analyzed using gas chromatography coupled to mass spectrometry (GC/MS). The major compounds identified in the EoWs are nerolidyl acetate (21.44%), β-Eudesmol (19.47%), linalool (16.48%), 1-terpinene-4-ol (10.93%), and cineole (5.34%). EoWs is relatively safe in the case of acute intake up to 2 g/kg body weight of albino mice. The effect of EoWs on intestinal relaxation was investigated using rabbit and rat jejunal smooth muscle. We have noticed that EoWs produce a myorelaxation on basal rabbit jejunum's contractions in a concentration-dependent manner with a maximal effect at 30 μg/mL. This myorelaxation was not dependent on adrenergic receptors. When the rat jejunums were pre-contracted with 25 mM KCl or 10 μM Carbachol (CCh), EoWs had an antispasmodic action with an IC50 values of 15.76 ± 0.37 and 12.04 ± 0.30 μg/mL, respectively. Preliminary results showed that it is probable that our plant might act directly through the NO and guanylate cyclase signaling pathway and on muscarinic but not nicotinic receptors. The results reveal that the Essential oil of W. saharae appears to have an impact on intestinal relaxation in vitro conditions. This finding lends credence to the traditional usage of this plant to treat intestinal disorders.

菊科是被子植物中最大的科之一,有几种药用和芳香植物。Warionia属在这个科中只有一种,Warionia sahara。在摩洛哥传统医学中,这种植物被广泛用于治疗胃肠道疾病。研究了该植物精油可能的肌肉松弛和抗痉挛活性,以使其一些传统用途合理化。本研究采用加氢蒸馏法从干燥植物提取物(EoWs)的空中部分提取精油,然后采用气相色谱-质谱联用(GC/MS)对其进行分析。主要化合物为醋酸橙树酯(21.44%)、β-桉树酚(19.47%)、芳樟醇(16.48%)、1-松油烯-4-醇(10.93%)和桉树脑(5.34%)。白化病小鼠急性摄取量高达每公斤体重2克,白化病小鼠白化病ws相对安全。以家兔和大鼠空肠平滑肌为实验对象,研究了茯苓多糖对肠道松弛的影响。我们注意到,ews对家兔空肠收缩产生肌松弛作用,并呈浓度依赖性,在30 μg/mL时效果最大。这种肌肉松弛不依赖于肾上腺素能受体。以25 mM KCl或10 μM Carbachol (CCh)预收缩大鼠空肠时,ews具有抗痉挛作用,IC50值分别为15.76±0.37和12.04±0.30 μg/mL。初步结果表明,该植物可能直接通过NO和鸟苷酸环化酶信号通路作用于毒蕈碱受体而非烟碱受体。结果表明,在体外条件下,撒哈拉挥发油似乎对肠道松弛有影响。这一发现为这种植物治疗肠道疾病的传统用法提供了依据。
{"title":"The Antispasmodic Effect of <i>Warionia saharae</i> Essential Oil in Experimental Models and its Mechanism of Action.","authors":"Ouafa Amrani,&nbsp;Mohamed Marghich,&nbsp;Mohamed Addi,&nbsp;Christophe Hano,&nbsp;Jen-Tsung Chen,&nbsp;Hanane Makrane,&nbsp;Chakib Alem,&nbsp;Ahmed Karim,&nbsp;Mohammed Aziz","doi":"10.31083/j.fbs1402010","DOIUrl":"https://doi.org/10.31083/j.fbs1402010","url":null,"abstract":"<p><p>With several medicinal and aromatic species, the Asteraceae family is one of the largest angiosperm families. The genus <i>Warionia</i> is represented in this family by only one species, <i>Warionia saharae</i>. In Moroccan traditional medicine, this species is widely used to treat gastrointestinal problems. Essential oil of this plant (EoWs) was studied for possible myorelaxant and antispasmodic activities to rationalize some of the traditional uses. In this investigation, hydrodistillation was used to obtain the essential oil from the aerial part of the dry plant extract (EoWs), which was then analyzed using gas chromatography coupled to mass spectrometry (GC/MS). The major compounds identified in the EoWs are nerolidyl acetate (21.44%), β-Eudesmol (19.47%), linalool (16.48%), 1-terpinene-4-ol (10.93%), and cineole (5.34%). EoWs is relatively safe in the case of acute intake up to 2 g/kg body weight of albino mice. The effect of EoWs on intestinal relaxation was investigated using rabbit and rat jejunal smooth muscle. We have noticed that EoWs produce a myorelaxation on basal rabbit jejunum's contractions in a concentration-dependent manner with a maximal effect at 30 μg/mL. This myorelaxation was not dependent on adrenergic receptors. When the rat jejunums were pre-contracted with 25 mM KCl or 10 μM Carbachol (CCh), EoWs had an antispasmodic action with an IC50 values of 15.76 ± 0.37 and 12.04 ± 0.30 μg/mL, respectively. Preliminary results showed that it is probable that our plant might act directly through the NO and guanylate cyclase signaling pathway and on muscarinic but not nicotinic receptors. The results reveal that the Essential oil of <i>W. saharae</i> appears to have an impact on intestinal relaxation <i>in vitro</i> conditions. This finding lends credence to the traditional usage of this plant to treat intestinal disorders.</p>","PeriodicalId":73070,"journal":{"name":"Frontiers in bioscience (Scholar edition)","volume":"14 2","pages":"10"},"PeriodicalIF":0.0,"publicationDate":"2022-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40178489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Taxonomic position, antibiotic resistance and virulence factors of clinical Achromobacter isolates. 临床分离无色杆菌的分类位置、耐药性及毒力因素。
Pub Date : 2022-03-21 DOI: 10.31083/j.fbs1402009
Ad C Fluit, Jumamurat R Bayjanov, María Díez Aguilar, Barry Benaissa-Trouw, Michael M Tunney, Mireille van Westreenen, Jacques F Meis, J Stuart Elborn, Rafael Cantón, Miquel B Ekkelenkamp

The role of Achromobacter species in lung disease remains unclear. The aim of this study was to characterize Achromobacter isolated from persons with cystic fibrosis and from other clinical samples. Whole genome sequences from 101 Achromobacter isolates were determined (81 from patients with cystic fibrosis and 20 from other patients) and analysed. Taxonomic analysis showed nine species including two putative novel species. Thirty-five novel sequence types were present. The most active agent was co-trimoxazole followed by imipenem, but Minimal Inhibitory Concentrations (MICs) were high. Acquired antibiotic resistance genes were rare. Their presence did not correlate with minimal inhibitory concentrations suggesting that other mechanisms are involved. Genes for proposed virulence factors were present in only some isolates. Two putative novel species were identified. The putative virulence properties of Achromobacter involved in infections are variable. Despite the high MICs, acquired resistance genes are uncommon.

无色杆菌在肺部疾病中的作用尚不清楚。本研究的目的是表征从囊性纤维化患者和其他临床样本中分离的无色杆菌。对101株无色杆菌分离株(81株来自囊性纤维化患者,20株来自其他患者)的全基因组序列进行了测定和分析。分类分析发现9种,其中2种推定为新种。发现35种新的序列类型。活性最强的药物是复方新诺明,其次是亚胺培南,但最低抑菌浓度(mic)较高。获得性抗生素耐药基因罕见。它们的存在与最低抑制浓度无关,这表明涉及其他机制。所提出的毒力因子基因仅在部分分离株中存在。鉴定出两个假定的新种。参与感染的无色杆菌的假定毒力特性是可变的。尽管mic很高,但获得性耐药基因并不常见。
{"title":"Taxonomic position, antibiotic resistance and virulence factors of clinical <i>Achromobacter</i> isolates.","authors":"Ad C Fluit,&nbsp;Jumamurat R Bayjanov,&nbsp;María Díez Aguilar,&nbsp;Barry Benaissa-Trouw,&nbsp;Michael M Tunney,&nbsp;Mireille van Westreenen,&nbsp;Jacques F Meis,&nbsp;J Stuart Elborn,&nbsp;Rafael Cantón,&nbsp;Miquel B Ekkelenkamp","doi":"10.31083/j.fbs1402009","DOIUrl":"https://doi.org/10.31083/j.fbs1402009","url":null,"abstract":"<p><p>The role of <i>Achromobacter</i> species in lung disease remains unclear. The aim of this study was to characterize <i>Achromobacter</i> isolated from persons with cystic fibrosis and from other clinical samples. Whole genome sequences from 101 <i>Achromobacter</i> isolates were determined (81 from patients with cystic fibrosis and 20 from other patients) and analysed. Taxonomic analysis showed nine species including two putative novel species. Thirty-five novel sequence types were present. The most active agent was co-trimoxazole followed by imipenem, but Minimal Inhibitory Concentrations (MICs) were high. Acquired antibiotic resistance genes were rare. Their presence did not correlate with minimal inhibitory concentrations suggesting that other mechanisms are involved. Genes for proposed virulence factors were present in only some isolates. Two putative novel species were identified. The putative virulence properties of <i>Achromobacter</i> involved in infections are variable. Despite the high MICs, acquired resistance genes are uncommon.</p>","PeriodicalId":73070,"journal":{"name":"Frontiers in bioscience (Scholar edition)","volume":"14 2","pages":"9"},"PeriodicalIF":0.0,"publicationDate":"2022-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40178488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aldehyde Dehydrogenase Enzyme Functions in Acute Leukemia Stem Cells. 醛脱氢酶在急性白血病干细胞中的作用。
Pub Date : 2022-03-08 DOI: 10.31083/j.fbs1401008
Garrett M Dancik, Ioannis F Voutsas, Spiros Vlahopoulos

The enzymes that belong to the aldehyde dehydrogenase family are expressed in a variety of cells; yet activity of their main members characterizes stem cells, both normal and malignant. Several members of this family perform critical functions in stem cells, in general, and a few have been shown to have key roles in malignant tumors and their recurrence. In particular, ALDH1A1, which localizes to the cytosol and the nucleus, is an enzyme critical in cancer stem cells. In acute myeloid leukemia (AML), ALDH1A1 protects leukemia-initiating cells from a number of antineoplastic agents, and proves vital for the establishment of human AML xenografts in mice. ALDH2, which is located in mitochondria, has a major role in alcohol metabolism by clearing ethanol-derived acetaldehyde. Haematopoietic stem cells require ALDH2 for protection against acetaldehyde, which can cause damage to DNA, leading to insertions, deletions, chromosomal rearrangements, and translocations. Mutations compromise stem cell function, and thereby threaten blood homeostasis. We review here the potential of targeting the enzymatic activity of aldehyde dehydrogenases in acute leukemia.

醛脱氢酶家族的酶在多种细胞中表达;然而,它们的主要成员的活动是干细胞的特征,无论是正常的还是恶性的。一般来说,这个家族的几个成员在干细胞中发挥关键作用,其中一些已被证明在恶性肿瘤及其复发中起关键作用。特别是定位于细胞质和细胞核的ALDH1A1,是癌症干细胞中至关重要的酶。在急性髓性白血病(AML)中,ALDH1A1保护白血病起始细胞免受许多抗肿瘤药物的影响,并证明了在小鼠中建立人类AML异种移植物的重要作用。ALDH2位于线粒体中,通过清除乙醇衍生的乙醛在酒精代谢中起主要作用。造血干细胞需要ALDH2来保护其免受乙醛的侵害,乙醛会导致DNA损伤,导致插入、缺失、染色体重排和易位。突变损害干细胞功能,从而威胁血液稳态。本文综述了靶向急性白血病中乙醛脱氢酶活性的潜力。
{"title":"Aldehyde Dehydrogenase Enzyme Functions in Acute Leukemia Stem Cells.","authors":"Garrett M Dancik,&nbsp;Ioannis F Voutsas,&nbsp;Spiros Vlahopoulos","doi":"10.31083/j.fbs1401008","DOIUrl":"https://doi.org/10.31083/j.fbs1401008","url":null,"abstract":"<p><p>The enzymes that belong to the aldehyde dehydrogenase family are expressed in a variety of cells; yet activity of their main members characterizes stem cells, both normal and malignant. Several members of this family perform critical functions in stem cells, in general, and a few have been shown to have key roles in malignant tumors and their recurrence. In particular, ALDH1A1, which localizes to the cytosol and the nucleus, is an enzyme critical in cancer stem cells. In acute myeloid leukemia (AML), ALDH1A1 protects leukemia-initiating cells from a number of antineoplastic agents, and proves vital for the establishment of human AML xenografts in mice. ALDH2, which is located in mitochondria, has a major role in alcohol metabolism by clearing ethanol-derived acetaldehyde. Haematopoietic stem cells require ALDH2 for protection against acetaldehyde, which can cause damage to DNA, leading to insertions, deletions, chromosomal rearrangements, and translocations. Mutations compromise stem cell function, and thereby threaten blood homeostasis. We review here the potential of targeting the enzymatic activity of aldehyde dehydrogenases in acute leukemia.</p>","PeriodicalId":73070,"journal":{"name":"Frontiers in bioscience (Scholar edition)","volume":"14 1","pages":"8"},"PeriodicalIF":0.0,"publicationDate":"2022-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40316679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
Frontiers in bioscience (Scholar edition)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1